Serum regucalcin is a useful indicator of liver injury severity in patients with hepatitis B virus-related liver diseases
Author:
Affiliation:
1. Beijing Youan Hospital, Capital Medical University, China
2. Beijing Institute of Hepatology, Capital Medical University, China
3. Beijing Youan Hospital, Beijing Key Laboratory for HIV/AIDS Research, China
Publisher
FapUNIFESP (SciELO)
Subject
Cell Biology,General Pharmacology, Toxicology and Pharmaceutics,General Medicine,Immunology,Physiology,Biochemistry,General Neuroscience,Biophysics,General Medicine
Link
http://www.scielo.br/pdf/bjmbr/v52n10/1414-431X-bjmbr-52-10-e8845.pdf
Reference30 articles.
1. Systematic review with meta-analysis: the proportion of chronic hepatitis B patients with normal alanine transaminase ≤40 IU/L and significant hepatic fibrosis;Chao DT;Aliment Pharmacol Ther,2014
2. Exogenous regucalcin suppresses the growth of human liver cancer HepG2 cells in vitro;Yamaguchi M;Oncol Rep,2018
3. Role of regucalcin in brain calcium signaling: involvement in aging;Yamaguchi M;Integr Biol (Camb),2012
4. Role of regucalcin in cell nuclear regulation: involvement as a transcription factor;Yamaguchi M;Cell Tissue Res,2013
5. Senescence marker protein 30 functions as gluconolactonase in L-ascorbic acid biosynthesis, and its knockout mice are prone to scurvy;Kondo Y;Proc Natl Acad Sci USA,2006
Cited by 3 articles. 订阅此论文施引文献 订阅此论文施引文献,注册后可以免费订阅5篇论文的施引文献,订阅后可以查看论文全部施引文献
1. Regucalcin Is a Potential Regulator in Human Cancer: Aiming to Expand into Cancer Therapy;Cancers;2023-11-20
2. Functional pleiotropy of calcium binding protein Regucalcin in signaling and diseases;Cellular Signalling;2023-02
3. Chromosome X riddle in SARS-CoV-2 (COVID-19) - related lung pathology;Pathology & Oncology Research;2020-07-20
1.学者识别学者识别
2.学术分析学术分析
3.人才评估人才评估
"同舟云学术"是以全球学者为主线,采集、加工和组织学术论文而形成的新型学术文献查询和分析系统,可以对全球学者进行文献检索和人才价值评估。用户可以通过关注某些学科领域的顶尖人物而持续追踪该领域的学科进展和研究前沿。经过近期的数据扩容,当前同舟云学术共收录了国内外主流学术期刊6万余种,收集的期刊论文及会议论文总量共计约1.5亿篇,并以每天添加12000余篇中外论文的速度递增。我们也可以为用户提供个性化、定制化的学者数据。欢迎来电咨询!咨询电话:010-8811{复制后删除}0370
www.globalauthorid.com
TOP
Copyright © 2019-2024 北京同舟云网络信息技术有限公司 京公网安备11010802033243号 京ICP备18003416号-3